Change of absolute neutrophil count after intravenous immunoglobulin administration for the children with idiopathic thrombocytopenic purpura |
Shin, Hyun Jung
(Department of Pediatrics Keimyung University School of Medicine)
Bang, In Kug (Department of Pediatrics Keimyung University School of Medicine) Choe, Byung Kyu (Department of Pediatrics Keimyung University School of Medicine) Hwang, Jin-Bok (Department of Pediatrics Keimyung University School of Medicine) Kim, Jun Sik (Department of Pediatrics Keimyung University School of Medicine) Kim, Heung Sik (Department of Pediatrics Keimyung University School of Medicine) |
1 | Berkovitch M, Dolinski G, Tauber T, Aladjem M, Kaplinsky C. Neutropenia as a complication of intravenous immunoglobulin(IVIG) therapy in children with immune thrombocytopenic purpura: common and non-alarming. Int J Immunopharmacol 1999;21:411-5 DOI ScienceOn |
2 | Niebanck AE, Kwiatkowski JL, Raffini LJ. Neutropenia following IVIG therapy in pediatric patients with immunemediated thrombocytopenia. J Pediatr Hematol Oncol 2005; 27:145-7 DOI ScienceOn |
3 | Beck CE, Nathan PC, Parkin PC, Blanchette VS, Macarthur C. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr 2005;147:521-7 DOI ScienceOn |
4 | Tam DA, Morton LD, Stroncek DF, Leshner RT. Neutropenia in a patient receiving intravenous immune globulin. J Neuroimmunol 1996;64:175-8 DOI ScienceOn |
5 | Tsujimoto H, Takeshita S, Nakatani K, Kawamura Y, Tokutomi T, Sekine I. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease. Clin Immunol 2002;103:161-8 DOI ScienceOn |
6 | Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002;346:995-1008 DOI ScienceOn |
7 | Sugita K, Eguchi M. Suppressive effect of intravenous immunoglobulin on peripheral blood neutrophil count in patients with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2005;27:7-10 DOI ScienceOn |
8 | Watts RG. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the Childrens Hospital of Alabama. Clin Pediatr(Phila) 2004;43:691-702 DOI |
9 | Schiavotto C, Ruggeri M, Rodeghiero F. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica 1993;78: 35-40 |
10 | Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, et al. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diag nosed immune thrombocytopenic purpura in children. J Pediatr 2006;148:489-94 DOI ScienceOn |
11 | Orbach H, Katz U, Sherer Y, Shoenfeld Y. Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol 2005;29:173-84 DOI ScienceOn |
12 | Nugent DJ. Immune thrombocytopenic purpura of childhood. Hematology Am Soc Hematol Educ Program 2006:97-103 |
13 | Bolton-Maggs P. Severe bleeding in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2003;25(Suppl 1): S47-51 DOI ScienceOn |
14 | Treutiger I, Rajantie J, Zeller B, Henter JI, Elinder G, Rosthoj S. Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity? Arch Dis Child 2007;92:704 -7 DOI ScienceOn |
15 | Tarantino MD, Madden RM, Fennewald DL, Patel CC, Bertolone SJ. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. J Pediatr 1999;134:21-6 DOI ScienceOn |
16 | Teeling JL, De Groot ER, Eerenberg AJ, Bleeker WK, Van Mierlo G, Aarden LA, et al. Human intravenous irnmuno globulin(IVIG) preparations degranulate human neutrophils in vitro. Clin Exp Immunol 1998;114:264-70 DOI |
17 | Altznauer F, von Gunten S, Spath P, Simon HU Concurrent presence of agonistic and antagonistic anti-CD95 autoantibodies in intravenous Ig preparations. J Allergy Clin Immunol 2003;112:1185-90 DOI ScienceOn |
18 | Benesch M, Kerbl R, Lackner H, Berghold A, Schwinger W, Triebl-Roth K, et al. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial. J Pediatr Hematol Oncol 2003;25:797 -800 DOI ScienceOn |
19 | Bolton-Maggs PH. Idiopathic thrombocytopenic purpura. Arch Dis Child 2000;83:220-2 DOI |
20 | Kuhne T, Buchanan GR, Zimmerman S, Michaels LA, Kohan R, Berchtold W, et al. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpuratl (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr 2003;143: 605-8 DOI ScienceOn |
21 | Blanchette V, Carcao M. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura. Transfus Sci 1998;19:279-88 DOI ScienceOn |
22 | Lee JH, Lee KS. Efficacy of very low-dose(200 mg/kg /d) with short-term intravenous immunoglobulin G therapy according to individual response of acute immune thrombocytopenic purpura in childhood. Clin Pediatr Hematol Oncol 2006;13:143-9 |
23 | Park JA, Park SS, Lim YT. Neutropenia following IVIG treatment in children with idiopathic thrombocytopenic purpura. In: Program & Abstract, the 56th Annual Fall Meeting of the Korean Pediatric Society; 2006. p. 113 |
24 | Imbach P, Barandun S, d' Apuzzo V, Baumgartner C, Hirt A, Morell A, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;1:1228-31 |